Pharmalot (Free subscription) | 09/04/2008
The usefulness of some cancer meds is being exaggerated because drugmakers are stopping trials the moment they find a benefit, according to a study that will be published in Annals of Oncology, The Telegraph reports. Researchers have discovered a sharp increase in the number of studies that are terminated early and argue that drugmakers are halting trials whenever benefits are discovered - and use...
The Telegraph (Free subscription) | 09/04/2008
The usefulness of some cancer drugs is being exaggerated because manufacturers are stopping trials the moment they find a benefit, experts will warn today.
Kevin, M.D. - Medical Weblog (Free subscription) | 09/04/2008
Companies are halting studies the moment a positive result arises: Researchers have discovered a sharp increase in the number of studies that are terminated early and argue that drugmakers are halting trials whenever benefits are discovered - and use the premature results as the basis for license applications. As a result, the researchers claim, drugs that are hailed as breakthroughs could be of less...
